Business Context and Reporting Period
This Form 8-K Current Report was filed by Repligen Corp on January 6, 2026. The filing addresses corporate governance changes, specifically the departure of the current Executive Chair and the election of a new Chair of the Board.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on personnel changes and does not contain financial performance data.
Material Changes
- Leadership Transition: The Board of Directors elected Dr. Martin D. Madaus as Chair of the Board, effective March 13, 2026.
- Retirement: Tony J. Hunt, currently serving as Executive Chair, will retire on the same effective date (March 13, 2026) and will cease to be a member of the Board.
- Independence: The Board has determined that Dr. Madaus is an independent director under SEC and Nasdaq rules.
Guidance, Outlook, and Risks
The filing does not contain financial guidance, operational outlook, or specific risk factors beyond the standard disclosure regarding the transition of leadership. The information is furnished under Regulation FD and is not deemed "filed" for liability purposes under Section 18 of the Exchange Act.
Investor Verification Checklist
- Verify the effective date of the leadership transition (March 13, 2026).
- Confirm Dr. Martin D. Madaus's independence status and background.
- Review the attached press release (Exhibit 99.1) for additional context on the succession plan.
- Note that no financial metrics are disclosed in this specific filing.